These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 28347987)

  • 1. Outcome prioritisation tool for medication review in older patients with multimorbidity: a pilot study in general practice.
    van Summeren JJ; Schuling J; Haaijer-Ruskamp FM; Denig P
    Br J Gen Pract; 2017 Jul; 67(660):e501-e506. PubMed ID: 28347987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eliciting Preferences of Multimorbid Elderly Adults in Family Practice Using an Outcome Prioritization Tool.
    van Summeren JJ; Haaijer-Ruskamp FM; Schuling J
    J Am Geriatr Soc; 2016 Nov; 64(11):e143-e148. PubMed ID: 27612181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication management strategy for older people with polypharmacy in general practice: a qualitative study on prescribing behaviour in primary care.
    Sinnige J; Korevaar JC; van Lieshout J; Westert GP; Schellevis FG; Braspenning JC
    Br J Gen Pract; 2016 Aug; 66(649):e540-51. PubMed ID: 27266862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving medication management in multimorbidity: development of the MultimorbiditY COllaborative Medication Review And DEcision Making (MY COMRADE) intervention using the Behaviour Change Wheel.
    Sinnott C; Mercer SW; Payne RA; Duerden M; Bradley CP; Byrne M
    Implement Sci; 2015 Sep; 10():132. PubMed ID: 26404642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supporting prescribing in older people with multimorbidity and significant polypharmacy in primary care (SPPiRE): a cluster randomised controlled trial protocol and pilot.
    McCarthy C; Clyne B; Corrigan D; Boland F; Wallace E; Moriarty F; Fahey T; Hughes C; Gillespie P; Smith SM
    Implement Sci; 2017 Aug; 12(1):99. PubMed ID: 28764753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilot study to test the feasibility of a trial design and complex intervention on PRIoritising MUltimedication in Multimorbidity in general practices (PRIMUMpilot).
    Muth C; Harder S; Uhlmann L; Rochon J; Fullerton B; Güthlin C; Erler A; Beyer M; van den Akker M; Perera R; Knottnerus A; Valderas JM; Gerlach FM; Haefeli WE
    BMJ Open; 2016 Jul; 6(7):e011613. PubMed ID: 27456328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in prescribed medicines in older patients with multimorbidity and polypharmacy in general practice.
    von Buedingen F; Hammer MS; Meid AD; Müller WE; Gerlach FM; Muth C
    BMC Fam Pract; 2018 Jul; 19(1):131. PubMed ID: 30055583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polypharmacy in chronic diseases-Reduction of Inappropriate Medication and Adverse drug events in older populations by electronic Decision Support (PRIMA-eDS): study protocol for a randomized controlled trial.
    Sönnichsen A; Trampisch US; Rieckert A; Piccoliori G; Vögele A; Flamm M; Johansson T; Esmail A; Reeves D; Löffler C; Höck J; Klaassen-Mielke R; Trampisch HJ; Kunnamo I
    Trials; 2016 Jan; 17():57. PubMed ID: 26822311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPs' management of polypharmacy and therapeutic dilemma in patients with multimorbidity: a cross-sectional survey of GPs in France.
    Carrier H; Zaytseva A; Bocquier A; Villani P; Verdoux H; Fortin M; Verger P
    Br J Gen Pract; 2019 Apr; 69(681):e270-e278. PubMed ID: 30803978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of a complex intervention on Prioritising Multimedication in Multimorbidity (PRIMUM) in primary care: results of a pragmatic cluster randomised controlled trial.
    Muth C; Uhlmann L; Haefeli WE; Rochon J; van den Akker M; Perera R; Güthlin C; Beyer M; Oswald F; Valderas JM; Knottnerus JA; Gerlach FM; Harder S
    BMJ Open; 2018 Feb; 8(2):e017740. PubMed ID: 29478012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-sectional study assessing health outcome priorities of older adults with multimorbidity at a primary care setting in Singapore.
    Ng XR; Tey YXS; Lew KJ; Lee PSS; Lee ES; Sim SZ
    BMJ Open; 2023 Dec; 13(12):e079990. PubMed ID: 38081675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review of general practice-based pharmacists' services to optimize medicines management in older people with multimorbidity and polypharmacy.
    Hasan Ibrahim AS; Barry HE; Hughes CM
    Fam Pract; 2021 Jul; 38(4):509-523. PubMed ID: 33506870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health professional perspectives on the management of multimorbidity and polypharmacy for older patients in Australia.
    Mc Namara KP; Breken BD; Alzubaidi HT; Bell JS; Dunbar JA; Walker C; Hernan A
    Age Ageing; 2017 Mar; 46(2):291-299. PubMed ID: 27836856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a clinical medication review focused on personal goals, quality of life, and health problems in older persons with polypharmacy: A randomised controlled trial (DREAMeR-study).
    Verdoorn S; Kwint HF; Blom JW; Gussekloo J; Bouvy ML
    PLoS Med; 2019 May; 16(5):e1002798. PubMed ID: 31067214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a tailored program on the implementation of evidence-based recommendations for multimorbid patients with polypharmacy in primary care practices-results of a cluster-randomized controlled trial.
    Jäger C; Freund T; Steinhäuser J; Stock C; Krisam J; Kaufmann-Kolle P; Wensing M; Szecsenyi J
    Implement Sci; 2017 Jan; 12(1):8. PubMed ID: 28086976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How general practitioners would deprescribe in frail oldest-old with polypharmacy - the LESS study.
    Mantelli S; Jungo KT; Rozsnyai Z; Reeve E; Luymes CH; Poortvliet RKE; Chiolero A; Rodondi N; Gussekloo J; Streit S
    BMC Fam Pract; 2018 Oct; 19(1):169. PubMed ID: 30314468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deprescribing medication in very elderly patients with multimorbidity: the view of Dutch GPs. A qualitative study.
    Schuling J; Gebben H; Veehof LJ; Haaijer-Ruskamp FM
    BMC Fam Pract; 2012 Jul; 13():56. PubMed ID: 22697490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A process evaluation of a cluster randomised trial to reduce potentially inappropriate prescribing in older people in primary care (OPTI-SCRIPT study).
    Clyne B; Cooper JA; Hughes CM; Fahey T; Smith SM;
    Trials; 2016 Aug; 17(1):386. PubMed ID: 27488272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimorbidity: can general practitioners identify the health conditions most important to their patients? Results from a national cross-sectional study in Switzerland.
    Déruaz-Luyet A; N'Goran AA; Pasquier J; Burnand B; Bodenmann P; Zechmann S; Neuner-Jehle S; Senn N; Widmer D; Streit S; Zeller A; Haller DM; Herzig L
    BMC Fam Pract; 2018 May; 19(1):66. PubMed ID: 29776442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a core outcome set for medication review in older patients with multimorbidity and polypharmacy: a study protocol.
    Beuscart JB; Dalleur O; Boland B; Thevelin S; Knol W; Cullinan S; Schneider C; O'Mahony D; Rodondi N; Spinewine A
    Clin Interv Aging; 2017; 12():1379-1389. PubMed ID: 28919724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.